DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Patanase (Olopatadine Hydrochloride Nasal) - Current Clinical Trials

 
 



Patanase Related Clinical Trials

Safety of PATANASE Nasal Spray in Patients With Perennial Allergic Rhinitis [Completed]

Olopatadine Hydrochloride Ophthalmic Solution Study in Chinese Subjects [Recruiting]

Safety and Comfort of AL-4943A Ophthalmic Solution [Completed]

Study of Olopatadine HCl Ophthalmic Solutions Compared to Vehicle Using the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis in Japanese Subjects [Completed]

Efficacy and Safety of AL-4943A Ophthalmic Solution in Patients With Allergic Conjunctivitis Using the Conjunctival Allergen Challenge (CAC) Model [Completed]

Efficacy and Safety of an Ophthalmic Solution in Patients With Allergic Conjunctivitis [Completed]

Alrex� Versus Patanol in the Treatment of Seasonal Allergic Conjunctivitis(SAC) [Completed]

A Study of Patient Perception and Quality of Life Associated With the Use of Olopatadine 0.2% in Subjects With Allergic Conjunctivitis [Completed]

Assessing the Efficacy of Maxidex® and Patanol® for the Treatment of Allergic Conjunctivitis [Completed]

Comparing Patient Satisfaction With Pataday or Bepreve [Completed]

Effectiveness of Olopatadine HCl Ophthalmic Solution for the Treatment of Allergic Conjunctivitis in Japan [Completed]

Safety and Pharmacokinetics of Patanase in Pediatric Patients 2 to < 6 Years of Age [Completed]

An Open-Label, Long-Term Study With AL-4943A Ophthalmic Solution, 0.2% in Patients With Allergic Conjunctivitis [Completed]

Clinical Efficacy of PRO-118 Compared With Olopatadine Hydrochloride Ophthalmic Solution in Allergic Conjunctivitis [Suspended]

Safety and Efficacy of Olopatadine Hydrochloride/Ketorolac Tromethamine Ophthalmic Solution Compared With Olopatadine Hydrochloride Ophthalmic Solution in Patients With Seasonal Allergic Conjunctivitis [Completed]

Confocal Analysis of Corneal Structures of Symptomatic Allergic Conjunctivitis Patients [Completed]

Olopatadine Eye Drops and Allergy Skin Testing [Completed]

Safety and Efficacy of Olopatadine HCl Nasal Spray in 6-11 Year Old Patients [Completed]

An Allergen BioCube (ABC) Study Evaluating the Onset of Action of Fluticasone Furoate Nasal Spray and Olopatadine Nasal Spray Compared to Placebo [Withdrawn]

Effect of Veramyst and Olopatadine 0.2% Opthalmic Solution on Allergy Symptoms [Completed]

A Study to Evaluate the Safety and Efficacy of the QLT Proprietary Olopatadine-PPDS in Subjects With Seasonal Allergic Conjunctivitis to Ragweed in an Environmental Exposure Chamber Model. [Terminated]

Comparison of Olopatadine 0.6% and Fluticasone Proprionate 50mcg Nasal Sprays in a Two Week Seasonal Allergic Rhinitis Trial [Completed]

Efficacy Investigation Study of Olopatadine Hydrochloride Ophthalmic Solution Using OHIO Chamber in Patients With Seasonal Allergic Rhinitis (SAR) [Completed]

Evaluation of the Safety and Efficacy of Ketotifen 4.0% Patch as Compared to Placebo Patch, Olopatadine 0.2% Ophthalmic Solution, and Artificial Tears in the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis [Completed]

Safety Study of Olopatadine Nasal Spray [Completed]

A Comparison of Olopatadine and Fluticasone in Patients With Allergic Conjunctivitis [Completed]

AGN-229666 Ophthalmic Solution in Japanese Patients With Allergic Conjunctivitis [Completed]

Safety and Efficacy of Olopatadine 0.6% and Azelastine 137 Mcg in Vasomotor Rhinitis [Completed]

A Six-Week Safety Study of an Investigational Ophthalmic Solution [Completed]

Mast-Cell Stabilizing Effects of Olopatadine [Completed]

Olopatadine 0.2% for the Treatment of Allergic Conjunctivitis [Completed]

Clinical Evaluation of 0.1% Olopatadine Hydrochloride Ophthalmic Solution in Pediatric Patients [Completed]

Comparison of the Efficacy and Tolerability of T1210 and Olopatadine Hydrochloride 0.1% in the Treatment of Seasonal Allergic Conjunctivitis [Completed]

Patient Perceptions and Quality of Life Associated With the Use of Olapatadine 0.2% for the Treatment of Allergic Conjunctivitis [Completed]

Evaluation of the Sensory Attributes of Olopatadine 0.6% and Azelastine 137mcg Nasal Sprays in Patients w/Allergic Rhinitis [Completed]

Patient Perception Study for AL-4943A [Completed]

Assessment of Alcon's Ocular Image Quantification System [Completed]

Study of DE-114 Ophthalmic Solution in Patients With Allergic Conjunctivitis [Completed]

Allergic Eye Disease Tear Mediators [Recruiting]

Comparison of Seasonal Allergic Rhinitis Treatment With 2 Antihistamines Used in Combination With Intranasal Corticosteroid [Completed]

To Study GSP 301 in Patients With Seasonal Allergic Rhinitis [Completed]

Comparison of CL Wear Between Two Allergy Drops [Withdrawn]

Study of Two Marketed Ocular Anti-Allergy Medications in Subjects With Allergic Conjunctivitis [Completed]

A Comparison of the Safety and Comfort of AC-170 [Completed]

Efficacy and Safety of Grass Sublingual Tablet in Adults (P05238 AM3)(COMPLETED) [Completed]

Efficacy and Safety of Grass Sublingual Tablet in Children and Adolescents (P05239 AM3)(COMPLETED) [Completed]

Long-Term Efficacy and Safety Study of SCH 900237/MK-8237 in Children and Adults With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis (P05607) [Completed]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017